| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| fenoldopam | alpha-1a adrenergic receptor | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Hypotension[MeSHID:D007022] Malignant Hypertension[MeSHID:D006974] Emergencies [Disease/Finding][MeSHID:D004630] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| fenoldopam | alpha-1b adrenergic receptor | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Hypotension[MeSHID:D007022] Malignant Hypertension[MeSHID:D006974] Emergencies [Disease/Finding][MeSHID:D004630] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| fenoldopam | alpha-1d adrenergic receptor | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Hypotension[MeSHID:D007022] Malignant Hypertension[MeSHID:D006974] Emergencies [Disease/Finding][MeSHID:D004630] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
| fenoldopam | alpha-2a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Hypotension[MeSHID:D007022] Malignant Hypertension[MeSHID:D006974] Emergencies [Disease/Finding][MeSHID:D004630] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.33 | approved | antagonist |
| fenoldopam | alpha-2b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Hypotension[MeSHID:D007022] Malignant Hypertension[MeSHID:D006974] Emergencies [Disease/Finding][MeSHID:D004630] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.4 | approved | antagonist |
| fenoldopam | alpha-2c adrenergic receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Hypotension[MeSHID:D007022] Malignant Hypertension[MeSHID:D006974] Emergencies [Disease/Finding][MeSHID:D004630] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.34 | approved | antagonist |
| fenoldopam | dopamine d1 receptor | small molecule | Successful target | TTD , drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Hypotension[MeSHID:D007022] Malignant Hypertension[MeSHID:D006974] Emergencies [Disease/Finding][MeSHID:D004630] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.34 | approved | agonist |
| fenoldopam | dopamine d5 receptor | small molecule | NA | drugbank , DGIDB | Hypertensive disease[MeSHID:D006973] Disease Management[MeSHID:D019468] Hypotension[MeSHID:D007022] Malignant Hypertension[MeSHID:D006974] Emergencies [Disease/Finding][MeSHID:D004630] Term Birth[MeSHID:D047929] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.33 | approved | agonist |
| click here to return to the previous page | ||||||||